These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 10706079

  • 1. A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.
    Blutt SE, Polek TC, Stewart LV, Kattan MW, Weigel NL.
    Cancer Res; 2000 Feb 15; 60(4):779-82. PubMed ID: 10706079
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar 15; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 3. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
    Zhang X, Jiang F, Li P, Li C, Ma Q, Nicosia SV, Bai W.
    Clin Cancer Res; 2005 Jan 01; 11(1):323-8. PubMed ID: 15671562
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 5. Correspondence re: S. E. Blutt, T. C. Polek, L. V. Stewart, M. W. Kattan, and N. L. Weigel, A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. Cancer Res., 60: 779-782, 2000.
    Schwartz GG, Lokeshwar BL, Burnstein KL.
    Cancer Res; 2001 May 15; 61(10):4294. PubMed ID: 11358859
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
    Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE.
    Prostate; 2001 Jun 01; 47(4):293-303. PubMed ID: 11398177
    [Abstract] [Full Text] [Related]

  • 7. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.
    Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR.
    Urology; 1995 Sep 01; 46(3):365-9. PubMed ID: 7660511
    [Abstract] [Full Text] [Related]

  • 8. Induction of apoptosis and inhibition of prostate and breast cancer growth by BGP-15, a new calcipotriene-derived vitamin D3 analog.
    Berkovich L, Ben-Shabat S, Sintov AC.
    Anticancer Drugs; 2010 Jul 01; 21(6):609-18. PubMed ID: 20335794
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS.
    Urology; 1997 Dec 01; 50(6):999-1006. PubMed ID: 9426741
    [Abstract] [Full Text] [Related]

  • 10. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J.
    Endocrinology; 1998 Apr 01; 139(4):2102-10. PubMed ID: 9528999
    [Abstract] [Full Text] [Related]

  • 11. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
    Evans SR, Schwartz AM, Shchepotin EI, Uskokovic M, Shchepotin IB.
    Clin Cancer Res; 1998 Nov 01; 4(11):2869-76. PubMed ID: 9829754
    [Abstract] [Full Text] [Related]

  • 12. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
    Pantazis P, Chatterjee D, Wyche J, DeJesus A, Early J, Plaschke S, Giovanella B.
    J Exp Ther Oncol; 1996 Sep 01; 1(5):322-33. PubMed ID: 9414421
    [Abstract] [Full Text] [Related]

  • 13. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ.
    Prostate; 2004 Mar 01; 58(4):382-93. PubMed ID: 14968439
    [Abstract] [Full Text] [Related]

  • 14. EB1089 induces Skp2-dependent p27 accumulation, leading to cell growth inhibition and cell cycle G1 phase arrest in human hepatoma cells.
    Luo W, Chen Y, Liu M, Du K, Zheng G, Cai T, Zhang W, Zhao F, Yao T, Yang R, Chen J.
    Cancer Invest; 2009 Jan 01; 27(1):29-37. PubMed ID: 19160095
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer.
    Oades GM, Dredge K, Kirby RS, Colston KW.
    BJU Int; 2002 Oct 01; 90(6):607-16. PubMed ID: 12230626
    [Abstract] [Full Text] [Related]

  • 16. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 01; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
    Ghous Z, Akhter J, Pourgholami MH, Morris DL.
    Anticancer Res; 2008 Aug 01; 28(6A):3757-61. PubMed ID: 19189661
    [Abstract] [Full Text] [Related]

  • 18. Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer.
    El Abdaimi K, Papavasiliou V, Rabbani SA, Rhim JS, Goltzman D, Kremer R.
    Cancer Res; 1999 Jul 15; 59(14):3325-8. PubMed ID: 10416587
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O, Nazarova N, Tuohimaa P.
    Life Sci; 2005 Jun 17; 77(5):562-77. PubMed ID: 15904673
    [Abstract] [Full Text] [Related]

  • 20. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R.
    Clin Cancer Res; 2002 Nov 17; 8(11):3512-9. PubMed ID: 12429642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.